Get the Stockscreener App
2.73
4.20%
0.11
Kiora Pharmaceuticals Inc stock is traded at $2.73, with a volume of 27,058.
It is up +4.20% in the last 24 hours and down -9.90% over the past month.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
See More
Previous Close:
$2.62
Open:
$2.595
24h Volume:
27,058
Relative Volume:
0.06
Market Cap:
$9.37M
Revenue:
-
Net Income/Loss:
$2.81M
P/E Ratio:
-0.1902
EPS:
-14.3497
Net Cash Flow:
$7.14M
1W Performance:
-6.83%
1M Performance:
-9.90%
6M Performance:
-21.33%
1Y Performance:
-26.22%
1-Day Range:
$2.53
$2.73
1-Week Range:
$2.53
$2.99
52-Week Range:
$2.25
$4.18
Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
Name
Kiora Pharmaceuticals Inc
Sector
Industry
Phone
858-224-9600
Address
169 SAXONY RD., ENCINITAS
Compare KPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KPRX
Kiora Pharmaceuticals Inc
|
2.73 | 9.89M | 0 | 2.81M | 7.14M | -14.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Kiora Pharmaceuticals Inc Stock (KPRX) Latest News
Kiora Pharmaceuticals Inc. stock prediction for this weekJuly 2025 Earnings & Safe Swing Trade Setups - Newser
Ranking Kiora Pharmaceuticals Inc. among high performing stocks via toolsJuly 2025 Trends & Low Risk Growth Stock Ideas - Newser
Quantitative breakdown of Kiora Pharmaceuticals Inc. recent moveJuly 2025 Update & Safe Capital Allocation Plans - Newser
Leading vs lagging indicators on Kiora Pharmaceuticals Inc. performanceWeekly Stock Summary & Technical Confirmation Trade Alerts - Newser
Best data tools to analyze Kiora Pharmaceuticals Inc. stockQuarterly Portfolio Summary & Smart Allocation Stock Tips - Newser
Published on: 2025-08-20 03:16:49 - Newser
Is Kiora Pharmaceuticals Inc. stock entering bullish territoryCPI Data & Advanced Technical Analysis Signals - Newser
Will Kiora Pharmaceuticals Inc. stock recover after recent dropQuarterly Profit Summary & Consistent Growth Equity Picks - Newser
Volume spikes in Kiora Pharmaceuticals Inc. stock – what they meanQuarterly Trade Summary & Weekly Watchlist for Consistent Profits - Newser
Is now a turning point for Kiora Pharmaceuticals Inc.Earnings Trend Report & Real-Time Buy Signal Alerts - Newser
Key metrics from Kiora Pharmaceuticals Inc.’s quarterly data2025 Stock Rankings & Daily Market Momentum Tracking - Newser
Is Kiora Pharmaceuticals Inc. showing signs of accumulationJobs Report & Verified Swing Trading Watchlist - Newser
Kiora Pharmaceuticals Inc. stock trend outlook and recovery pathPortfolio Growth Summary & Community Shared Stock Ideas - Newser
Kiora Pharmaceuticals Inc. stock momentum explained2025 Trading Recap & Fast Gaining Stock Strategy Reports - Newser
Can swing trading help recover from Kiora Pharmaceuticals Inc. lossesForecast Cut & Advanced Technical Analysis Signals - Newser
Combining machine learning predictions for Kiora Pharmaceuticals Inc.Gap Up & Stepwise Trade Execution Plans - Newser
Visualizing Kiora Pharmaceuticals Inc. stock with heatmapsTrade Analysis Summary & Free Technical Pattern Based Buy Signals - Newser
Is Kiora Pharmaceuticals Inc. reversing from oversold territory2025 Risk Factors & Growth Focused Investment Plans - Newser
Technical analysis overview for Kiora Pharmaceuticals Inc. stockJuly 2025 Price Swings & Expert Curated Trade Setups - Newser
Statistical indicators supporting Kiora Pharmaceuticals Inc.’s strengthMarket Sentiment Review & Weekly Consistent Profit Watchlists - Newser
Applying big data sentiment scoring on Kiora Pharmaceuticals Inc.Share Buyback & Low Drawdown Momentum Ideas - Newser
Strategies to average down on Kiora Pharmaceuticals Inc.July 2025 Highlights & Verified Entry Point Signals - Newser
Is Kiora Pharmaceuticals Inc. still worth holding after the dipRisk Management & Daily Growth Stock Tips - Newser
Why Kiora Pharmaceuticals Inc. stock attracts strong analyst attentionForecast Cut & Daily Profit Maximizing Tips - beatles.ru
Full technical analysis of Kiora Pharmaceuticals Inc. stockJuly 2025 Decliners & Advanced Technical Analysis Signals - Newser
Can Kiora Pharmaceuticals Inc. stock recover from recent decline2025 Retail Activity & High Accuracy Trade Signal Alerts - Newser
Market reaction to Kiora Pharmaceuticals Inc.’s recent news2025 Buyback Activity & Weekly Chart Analysis and Guides - Newser
Applying chart zones and confluence areas to Kiora Pharmaceuticals Inc.Weekly Gains Summary & Real-Time Volume Spike Alerts - Newser
What earnings revisions data tells us about Kiora Pharmaceuticals Inc.Trend Reversal & Entry and Exit Point Strategies - Newser
Kiora Pharmaceuticals Inc. Added to Custom Quant Screener TodayIPO Watch & Technical Pattern Based Buy Signals - newsyoung.net
Reversal indicators forming on Kiora Pharmaceuticals Inc. stockChart Signals & Proven Capital Preservation Tips - Newser
Analyzing drawdowns of Kiora Pharmaceuticals Inc. with statistical toolsPortfolio Update Summary & Proven Capital Preservation Methods - Newser
Kiora Pharmaceuticals Inc Stock (KPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Kiora Pharmaceuticals Inc Stock (KPRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Shapiro Aron | Director |
Sep 10 '24 |
Buy |
3.60 |
3,000 |
10,800 |
3,000 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):